Reunion Neuroscience: Psychedelic Prodrug RE104 For The Treatment of Post-Partum Depression Moves Into Phase 2 Clinical Trials.
RE104 is a psychedelic prodrug that was safe and well tolerated by healthy participants in a phase 1 clinical trial. RE104 produced an effective response at 33 mg which will be the effective dose used in the phase 2 trial investigating its efficacy in the treatment...